MeNZB was a vaccine against a specific strain of group B meningococcus, used to control an epidemic of meningococcal disease in New Zealand. Most people... 9 KB (1,009 words) - 07:15, 2 September 2023 |
passed on to Chiron (now GlaxoSmithKline), who developed a similar vaccine, MeNZB, for New Zealand. A MenB vaccine was approved for use in Europe in January... 49 KB (4,270 words) - 05:45, 14 April 2024 |
added 2000: DTaP replaced DTwP 2002: IPV replaced OPV 2006: MeNZB and Tdap added 2008: MeNZB dropped, PCV7 added, HPV4 added for females only 2011: PCV10... 234 KB (2,836 words) - 00:32, 3 April 2024 |
Brucellosis Cholera# Diphtheria# Hib# Leptospirosis Lyme disease‡ Meningococcus# MeNZB NmVac4-A/C/Y/W-135 Pertussis# Plague Pneumococcal# PCV PPSV Q fever Tetanus#... 28 KB (3,115 words) - 12:09, 20 April 2024 |
Brucellosis Cholera# Diphtheria# Hib# Leptospirosis Lyme disease‡ Meningococcus# MeNZB NmVac4-A/C/Y/W-135 Pertussis# Plague Pneumococcal# PCV PPSV Q fever Tetanus#... 12 KB (1,267 words) - 05:50, 14 April 2024 |
Brucellosis Cholera# Diphtheria# Hib# Leptospirosis Lyme disease‡ Meningococcus# MeNZB NmVac4-A/C/Y/W-135 Pertussis# Plague Pneumococcal# PCV PPSV Q fever Tetanus#... 35 KB (4,070 words) - 10:53, 18 April 2024 |